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We have compared the erythema and tanning re-
sponses in skin type I (n ::: 15) and skin type IV (n ::: 17) 
Caucasoids following a single exposure to solar simu-
lated radiation. The former sunburn easily and do not 
tan while the latter do not burn and tan readily. The 
dose of radiation was 5 times the Minimal Erythema 
Dose (MED). The test sites were the extensor aspect of 
the forearm (exposed site) and flexor aspect of the upper 
arm (nonexposed site). The responses were monitored at 
24 and 48 hr and then twice weekly for 8 weeks. 
The group of skin type I individuals had a lower MED 
and a much more prolonged erythema on both the ex-
posed and nonexposed sites than the group of type IV 
individuals. All differences were highly significant (p < 
0.005). After 4 weeks erythema remained present in all 
of the type I subjects but had disappeared in 16 of the 17 
type IV subjects. Within the groups there was no differ-
ence between erythema duration on exposed vs. nonex-
posed sites, but there was a highly significant difference 
(p < 0.005) between the lower MED on the upper arm 
and higher MED on the forearm. 
These results contrast with those of other reports in 
which prolonged erythema could not be correlated with 
fair complexion, sunburn sensitivity, ethnic background, 
or skin type but was instead found to be a distinct feature 
of persons who had developed nonmelanoma skin can-
cer. Since prolonged erythema is related to skin type it 
is therefore not solely a feature of patients with skin 
cancer.' 
Carcinomas of the skin are related epidemiologically to sun-
light exposure. They occur most frequently on exposed sites 
[1], in outdoor workers, and in regions of low latitude and 
intense ultraviolet radiation (UVR) [2,3]. Important risk factors 
for the development of nonmelanoma carcinoma are solar ex-
posure and tanning ability [4]. A phenotype has been described 
for Caucasoids considered most at risk of developing skin can-
cer, namely fair skin, red or blond hair, blue or green eyes, easy 
sunburning, poor tanning, and frequently Celtic ancestry [5]. 
More recently, Tanenbaum et aI provided evidence that the 
risk of developing skin cancer is additionally linked to the 
development of prolonged erythema following exposure to ar-
tificial UVR [6]. Patients with skin cal'cinoma (predominently 
basal cell carcinoma) and non carcinoma controls were irradi-
ated with similar supra threshold doses of flltered UVR from a 
high pressure mercury arc and the erythema and tanning re-
sponses were recorded weekly for 3 weeks. They found no 
difference in the erythema response between the 2 groups 
following exposUTe to 2 and 4 times the minimum erythema 
dose (MED) . With a dose of 6 MED's, however, a significantly 
higher proportion of skin cancer patients still had erythema at 
2 and 3 weeks compared to the controls. At 8 MED's there was 
no difference between the groups with regards to the presence 
or absence of erythema, but a greater proportion of the cancer 
patients had a more intense reaction viz. 2+ as opposed to 1+ 
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erythema. The latter response to 8 MED's was defmed as 
"prolonged" erythema. Since prolonged UVR erythema did not 
correlate with fair skin, sunburn sensitivity or Celtic ancestry, 
it was concluded that it was an additional risk factor peculiar to 
skin cancer-prone individuals. 
In a later study Jung et aI confrrmed the apparent importance 
of prolonged erythema as a distinct risk factor for the devel-
opment of skin carcinoma [7]. They exposed the inner foreal·m 
to 8 MED's of 300 ± 10 nm radiation from a Xenon arc equipped 
with a monochromator and observed the responses for 3 weeks. 
Prolonged erythema, defined as "clear" redness present 2 weeks 
after irradiation, was found in 80% of a skin cancer group but in 
only 28% of the control group. They also compared the re-
sponses to 8 MED's in normal subjects of skin type I and skin 
type III, and found no significant difference between the 2 
groups. They concluded that prolonged erythema did not cor-
relate with skin type. 
While studying the time course of erythema in subjects of 
differing sun sensitivity we gained the impression that pro-
longed UVR erythema may indeed be related to established 
risk factors for skin cancer. The presence of these factors also 
seemed to correlate with a much lower erythema threshold 
dose. If true, this would suggest that prolonged UVR erythema 
may be related to skin type and therefore may not be solely a 
feature of patients who have developed skin cancer. 
Since the issue is of some importance and is unsettled, we 
conducted a study to compare the duration of UVR erythema 
in sun-sensitive and dark skinned Caucasoids. 
MATERIALS AND METHODS 
Subjects 
32 healthy Caucasoids between the ages of 18 and 42 took part in the 
study. None gave a history of abnormal reactions to sunlight. They 
were selected on the basis of their previous response to sunlight 
exposure. 15 subjects were skin type I and 17 were skin type IV [8]. 
Skin type II and III subjects were excluded. Eye color, hair color, ethnic 
background (e.g., Celtic, Mediterranean), presence or absence of frec-
kling, and history of sun exposure were recorded. Informed consent was 
obtained. 
UVR Source 
The UVR source was a 150 w xenon arc solru' simulator equipped 
with a I-mm Schott WG 320 filter (50% transmission at about 310 nm) 
and a 1 mm UG 11 filter [9]. The spectral irradiance (Fig 1) was 
measured by an International Light Spectroradiometer System (Model 
782). The irradiated fie ld was a 1 cm circle. Intensity measurements 
were made by a calibrated Eppley thermopile (Eppley Laboratories) 
attached to a millimicrovoltmeter. Intensity at skin surface was 74.3 
mw /cm2. The Minimal Erythema Dose (MED) was determined at each 
site by exposing the skin to 25% incremental doses of UVR, the MED 
being the smallest dose producing minimal uniform redness with shru'p 
borders 24 hr later. 
Experimental Design 
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The extensor aspect of the forearm (exposed site) and flexor aspect 
of the upper arm (unexposed site) were the test areas. Each site was 
irradiated once with 5 times the MED. Pilot studies showed that the 
erythema produced by 5 MED's is sufficiently prolonged to provide 
conclusive results without producing the degree of local damage that 
may be caused by larger doses. The sites were observed at 24 and 48 hr 
and then twice weekly for 8 weeks or until the erythema had completely 
faded. The presence and intensity of erythema and pigmentation and 
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FIG 1. Spectral irradiance of the 150-w xenon arc sol81· simulator. 
TABLE 1. Minimal erythema dose (MED) of ultraviolet radiation 
means ± standard deviation 
N Unexposed site (Upper inner arm) 
Exposed s iLe 
(Lateral forearm) 
Skin type I 
Skin type IV 
15 
17 
0.7 ± 0.1 J . cm- z 
2.1 ± 0.3 J. cm- 2 
1.3 ± 0.5 J. cm- 2 
3.5 ± 0.7 J. cm-1 
RESULTS 
The type I subjects were predominantly of Celtic (Irish, 
Welsh, or Scots) or mixed Celtic/North Ew-opean extraction. 
They were characterized by pale skin, blue or green eyes, blond 
or red hair and numerous blotchy freckles on sun exposed areas. 
The type IV subjects were in the main of Mediteranean or East 
European extraction with dark hair and brown eyes. Freckling 
was absent. 
MED's for the 2 groups at the 2 test sites are shown in Table 
L The MED's are significantly lower (p < 0.005) in type I 
subjects. Additionally in both skin types the MED is signifi-
cantly lower on the upper arm (p < 0.005). 
When observed at 24 hr, the majority of test sites in both 
groups showed intense erythema and edema. A minority had 
less marked reactions with moderate erythema and just detect-
able edema. Edema disappeared within one week in all subjects. 
No subjects in either group developed blisters although 73% of 
the skin type I subjects gave a history of blistering sunbw-n 
following inadvertent overexposw-e to natural sunlight. 
The intensity of erythema was maximal at 24 hr with slight 
fading already apparent at 48 hr in the type IV subjects. Type 
I subjects showed a more prolonged peak intensity of erythem·a 
lasting an average of 5 days before fading began to occw-. 
The time cow-se of the erythema is shown in Fig 2 and its 
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total duration in days in Table II. In 5 of the type I subjects 
erythema was still present at the termination of the study at 8 
weeks and in these subjects the dw-ation of the erythema was 
recorded as 56 days. Within each group the dw-ation of ery-
thema was the same on exposed and nonexposed sites, but at 
both test sites the erythema persisted much longer in type I 
subjects (p < 0.005). The striking difference between the 2 
groups is seen in Fig 2. After 4 weeks erythema was still present 
in all the type I subjects but had disappeared in 16 of the 17 
type IV subjects. 
Pigmentation developed consistently in type IV subjects. The 
precise time of onset was difficult to determine in the presence 
of intense erythema but pigmentation was present within 1 
week and was generally more intense on the forearm. Peeling 
occurred between 1 and 2 weeks characteristically leaving a 
hypopigmented center with an erythematous and hyperpig-
mented margin. In type I subjects faint pigmentation was 
evident at 3 to 4 weeks but only in 60% of subjects. Scaling and 
peeling were similar to type IV subjects. 
DISCUSSION 
Skin typing based on sunbw-ning and tanning has proved 
helpful in classifying individuals with respect to their sensitivity 
to solar radiation. The present findings provide additional tes-
timony to the usefulness of this classification. Type I individ-
uals, who have the well known characteristics commonly asso-
ciated with high risk for cutaneous carcinoma, reacted differ-
ently to a single challenge with UVR compared to skin type IV 
subjects. The latter are the least sun-sensitive among Cauca-
soids. The results confirmed our impression that UVR ery-
thema persists for a considerably longer period in type I indi-
viduals. Intense erythema also persisted longer before beginning 
to fade dw-ing the first week after irradiation. However, the 
most striking difference emerged by the end of the fourth week 
of observation when all 15 type Isubjects still had erythema 
compared to only one of the 17 type IV subjects. In some, 
erythema persisted beyond 8 weeks. This underscores the im-
portance of long follow-up. In both skin types the presence of 
scaling and peeling, especially between 10 and 14 days, often 
obscw-ed the presence of erythema. In the 2 studies alluded to 
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TIME IN WEEKS 
FIG 2. Percentage of subjects with erythema plotted against time in 
weeks after irradiation. Skin T ype I fore81·m (T - - - T ) and upper arm 
(9 - - - 9 ). Skin Type IV fore81·m (e- - - e) and upper 81·m (0 - - - 0 ). 
TABLE II. Duration of erythem.a following single exposure to 5 
MED'S Mea.ns ± standard deviation 
Skin type I 




Unexposed si te 
45.3 ± 8.8 Days 
17.5 ± 5.2 Days 
Exposed si Le 
48.7 ± 6.8 Days 
16.3 ± 6.4 Days 
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arbitrary period of two weeks was the criterion of prolonged 
erythema. 
In order to emphasize differences in response, the comparison 
was limited to the two polar groups at the extreme ends of the 
sun sensitivity scale. It may be appropriate to study type II and 
III individuals in a similar fashion. However, we suspect that 
the differences will not be nearly as sharp as those observed in 
this study. Jung et al [7] for ex!. '11ple, using a different statistical 
method of evaluation, were unable to show a significant differ-
ence in the MED between skin type I and skin type III subjects. 
It is important to interpret the present findings accurately. 
Comparison to the previously mentioned studies is not possible 
since no attempt was made here to investigate reactions in skin 
cancer patients. Moreover, there are differences in the UVR 
sources, dosages and definition of prolonged erythema. In the 
study by Tanenbaum et al [6] the control and cancer groups 
were not skin typed but each contained a comparable percent-
age of individuals of fair complexion and Celts. Their conclusion 
however that prolonged erythema is not correlated with fair 
complexion or other established risk factors for skin cancer does 
not agree with our findings. It is not clear from the study by 
Jung et al [7] whether significant differences were evident in 
"prolonged"erythema between the skin cancer and the skin 
type I groups. In marked contrast to our results only about 63% 
of their type I subjects had erythema at 2 weeks, even though 
they used a larger erythemogenic dose of 8 MED's. Their 
conclusion that there was no correlation between persistent 
erythema and skin type is not supported by our data. 
Since persistent UVR erythema appears to be a feature of 
skin type I skin and is therefore related to established risk 
factors for skin cancer, the question arises whether it provides 
additional information of prognostic significance in other skin 
types. It is conceivable that some darker individuals are at risk 
and have more prolonged erythema. This is an intriguing hy-
pothesis. However, we believe that a re-examination of the 
reported association of prolonged erythema with skin cancer 
would be appropriate. This would require careful matching of 
controls and cancer patients for skin type, and a longer follow-
up period. 
We have confirmed that there are important regional and 
anatomic differences in the MED [10). The threshold dose for 
the forearm was highel· than that for the relatively protected 
upper inner arm. The lower sensitivity of habitually exposed 
areas may be related to several factors such as thickness of the 
stratum corneum, accomodation to sunlight, vascular reactivity, 
etc. Nonetheless, it is noteworthy that there was no difference 
in the course or duration of UVR erythema between the 2 sites 
Vol. 77, No.6 
in anyone group when an equivalent erythemogenic dose was 
given. 
We have no explanation for the persistence ofUVR erythema 
in skin type I individuals, although it is tempting to speculate 
that they are deficient in repairing acute UVR injury. Another 
observation that requires further study is the development of 
hypopigmentation in type IV subjects, which became evident 
after desquamation occurred during the second week and per-
sisted for the entire study period. The cause for this unexpect~d 
finding is not clear, although it is possible that beyond a certaI? 
suprathreshold dose, UVR may actually inhibit melanogenesIs 
or may even be melanocidal. Furthermore, although skin type 
I subjects by defmition "never" tan, a few develop slight pig-
mentation after 5 MED's. Hypo- or depigmentation was n.ot 
observed. These striking differences in the erythemal and pig-
mentary responses between the 2 groups of subjects will have 
to be reckoned with when UVR studies are conducted in a 
mixed population. 
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